First-in-man study to evaluate safety, tolerability and pharmacokinetics of BAY 85-8501 in healthy male subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Nov 2015
At a glance
- Drugs BAY 85 8501 (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions; First in man; Pharmacokinetics
- 11 Nov 2015 New trial record